TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
CGC

Canopy Growth Corp

Healthcare · Drug Manufacturers - Specialty & Generic

0.8845$ +1.0% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Income Statement

Canopy Growth Corp (CGC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2026), "Revenue" came in at 285 million CAD. Tick rows to compare them in a chart.

All figures in millions of CAD.

Tick rows to compare them in a chart (up to 4)

Income Statement CGC
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
1.9 13 40 78 226 399 547 476 333 297 269 285
0.7 -6.3 2.3 3.8 137 430 480 663 397 216 189 215
0.4 19 39 74 89 -32 67 -187 -64 81 80 70
0.2 0.7 0.8 1.5 15 62 58 32 22 4.6 1.9 –
6.0 12 26 93 451 625 329 173 161 104 61 60
8.2 22 53 153 643 1,637 1,310 831 2,567 310 197 143
-6.6 -2.7 -14 -108 -615 -1,669 -1,243 -1,019 -2,631 -229 -117 -73
0.1 0.1 0.1 0.8 18 6.7 8.5 104 126 105 75 38
-7.5 -3.4 -10 -51 -709 -1,509 -1,684 -268 -3,086 -471 -597 -263
1.4 0.1 2.7 -0.4 4.1 -122 -13 -8.9 -5.7 12 7.1 0.0
-8.9 -3.5 -7.5 -67 -736 -1,321 -1,745 -310 -3,278 -657 -598 -263
-6.1 0.9 -0.7 -96 -567 -1,377 -450 -53 -2,880 -313 -479 -188

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?